Skip to content

SURPLUS-trial

A randomized trial to assess the SURPLUS value of telehealth for the Catharina Obesity Centre

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON23994
Enrollment
150
Registered
2014-09-15
Start date
2014-12-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric surgery

Interventions

150 selected patients postoperatively in the obesity center randomly divided into 3 groups
(1) standard counseling (2) standard counseling + online coaching modules (3) standard counseling + online coaching modules + wireless remote monitoring for the period of 12 months

Sponsors

Investigator Initiated Study / Obesity Center Catharina Hospital Eindhoven
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - A body mass index above 40 kg/m2 or above 35 kg/m2 with related comorbidity (hypertension, diabetes type 2, hyperlipidaemia, obstructive sleep apnoea syndrome or joint arthritis of lower limbs) - A gastric sleeve / bypass / revision planned - Completed the bariatric screening questionnaire online - Having ongoing access to internet - Ability to use a model of mobile device (smartphone or tablet) with any version of the Android or iOS platform - Age of 18 years or more - Ability to read and write the Dutch language - Signed informed consent

Exclusion criteria

Exclusion criteria: Not fulfilling the selectioncriteria

Design outcomes

Primary

MeasureTime frame
Numeric Rating Scale for decision making after 12 months

Secondary

MeasureTime frame
Verbal Descriptor Scale satisfactorily patients and caretakers Quality of life with RAND 36 questionnaire Reduction in weight and comorbidities Number of additional telephone contacts not leading to medical intervention Frequency technical failures of the wireless monitoring devices

Contacts

Public ContactS.W. Nienhuijs

Michelangelolaan 2

simon.nienhuijs@cze.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)